{
    "pubmed_id": 34001652,
    "study_identifier": "PMID34001652_study-01",
    "study_name": "One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses",
    "publication_title": "One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses",
    "study_objective": "In this study, we develop a sensitive anti\u2013SARS-CoV-2 immunoassay, using prepandemic controls and RT-PCR\u2013confirmed, SARS-CoV-2\u2013infected patients",
    "study_description": "We developed a multiplex immunoassay from serum/plasma of acutely infected and convalescent COVID-19 patients and prepandemic and postpandemic healthy adults. We measured IgA, IgG, and/or IgM against SARS-CoV-2 nucleocapsid (N), spike domain 1 (S1), S1-receptor binding domain (RBD) and S1-N-terminal domain. For diagnosis, the combined [IgA + IgG + IgM] or IgG levels measured for N, S1, and S1-RBD yielded area under the curve values \u22650.90. Virus-specific Ig levels were higher in patients with severe/critical compared with mild/moderate infections. A strong prozone effect was observed in sera from severe/critical patients-a possible source of underestimated Ab concentrations in previous studies. Mild/moderate patients displayed a slower rise and lower peak in anti-N and anti-S1 IgG levels compared with severe/critical patients, but anti-RBD IgG and neutralization responses reached similar levels at 2-4 mo after symptom onset. Measurement of the Ab responses in sera from 18 COVID-19-vaccinated patients revealed specific responses for the S1-RBD Ag and none against the N protein. This highly sensitive, SARS-CoV-2-specific, multiplex immunoassay measures the magnitude, complexity, and kinetics of the Ab response and can distinguish serum Ab responses from natural SARS-CoV-2 infections (mild or severe) and mRNA COVID-19 vaccines.",
    "primary_institution_name": "Emory University",
    "study_personnel": [
        {
            "personnel_id": "PMID34001652_personnel-01",
            "honorific": "",
            "last_name": "Sanz",
            "first_name": "Ignacio",
            "suffixes": "",
            "organization": "Emory University",
            "orchid_id": "",
            "email": "ignacio.sanz@emory.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "Co-Principal Investigator",
            "site_name": "EMORY UNIVERSITY"
        }
    ],
    "study_file": [
        {
            "study_file_name": "immunohorizon_2100011_Supplemental_1.pdf",
            "study_file_description": "Figure S1, S2 and S3, Table S1",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "Haddad COVID-19 Luminex Serum Data 20220606.xlsx",
            "study_file_description": "Luminex Serum Data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID34001652_v1.2.3.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Vaccine response",
    "study_type": "Method Development",
    "keyword": [
        "Adult",
        "Aged",
        "Antibodies",
        "Viral",
        "blood",
        "immunology",
        "COVID-19 Vaccines",
        "administration & dosage",
        "prevention & control",
        "Female",
        "Humans",
        "Immunoassay",
        "Male",
        "Middle Aged",
        "SARS-CoV-2",
        "metabolism",
        "Severity of Illness Index",
        "Vaccination"
    ],
    "clinical_study_design": "",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID34001652_protocol-01",
        "protocol_file_name": "PMID34001652_protocol-01.txt",
        "protocol_name": "PMID34001652_protocol-01",
        "protocol_description": "study protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "Pfizer-BioNTech",
        "Moderna"
    ],
    "clinical_outcome_measure": "",
    "enrollment_start_date": "",
    "enrollment_end_date": "",
    "number_of_study_subjects": 366,
    "age_unit": "Years",
    "minimum_age": 21,
    "maximum_age": 81,
    "study_human_cohort": [
        {
            "arm_id": "PMID34001652_human_subject-01",
            "arm_name": "Patients with Convalescent COVID-19",
            "study_population_description": "Patients with Convalescent COVID-19 (n = 69)",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "White",
                "Black or African American",
                "Asian"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Georgia"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Mild",
                "Moderate",
                "Severe",
                "Critical"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID34001652_human_subject-02",
            "arm_name": "Patients with Acute COVID-19 (n = 52)",
            "study_population_description": "Patients with acute COVID-19 (n = 52)",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "White",
                "Black or African American",
                "Asian"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Georgia"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Mild",
                "Severe",
                "Critical"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID34001652_human_subject-03",
            "arm_name": "Vaccinated patients",
            "study_population_description": "COVID-19\u2013vaccinated patients (n = 18)",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "White",
                "Black or African American",
                "Asian"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Georgia"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine ; VO:0004987",
                "Moderna COVID-19 vaccine ; VO:0005157"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID34001652_human_subject-04",
            "arm_name": "Prepandemic Healthy Adults",
            "study_population_description": "Prepandemic Healthy Adults (n = 106)",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "White",
                "Black or African American",
                "Asian"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Georgia"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID34001652_human_subject-05",
            "arm_name": "Postpandemic Healthy Adults",
            "study_population_description": "Postpandemic Healthy Adults (n = 137)",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "White",
                "Black or African American",
                "Asian"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Georgia"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID34001652_visit-01",
            "visit_name": "Blood collection patients with Convalescent COVID-19",
            "visit_order_number": 1,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34001652_visit-02",
            "visit_name": "Blood collection patients with Acute COVID-19",
            "visit_order_number": 2,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34001652_visit-03",
            "visit_name": "Blood collection vaccinated patients",
            "visit_order_number": 3,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34001652_visit-04",
            "visit_name": "Blood collection prepandemic Healthy Adults",
            "visit_order_number": 4,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34001652_visit-05",
            "visit_name": "Blood collection postpandemic Healthy Adults",
            "visit_order_number": 5,
            "visit_min_start_day": 910,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID34001652_human_subject-01, PMID34001652_human_subject-02, PMID34001652_human_subject-03"
            ],
            "associated_first_planned_visit_id": [
                "PMID34001652_visit-01, PMID34001652_visit-02, PMID34001652_visit-03"
            ],
            "assay_type": "Multiplex Immunoassay",
            "experiment_name": "Serum Ab responses",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "nucleocapsid",
                "S1",
                "Receptor Binding Domain (RBD)",
                "N-terminal Domain (NTD)"
            ],
            "assay_use": "Research Use Only",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgA",
                "IgG",
                "IgM"
            ],
            "reporting_units": "Other",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID34001652_human_subject-04, PMID34001652_human_subject-05"
            ],
            "associated_first_planned_visit_id": [
                "PMID34001652_visit-04, PMID34001652_visit-05"
            ],
            "assay_type": "Multiplex Immunoassay",
            "experiment_name": "Multiplex Immunoassay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Na\u00efve"
            ],
            "sars_cov_2_antigen": [
                "nucleocapsid",
                "S1",
                "Receptor Binding Domain (RBD)",
                "N-terminal Domain (NTD)"
            ],
            "assay_use": "Research Use Only",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgA",
                "IgG",
                "IgM"
            ],
            "reporting_units": "Other",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "Yes",
    "pediatric_subjects": "No",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Not Specified",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID34001652_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34001652_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "exclusion"
        }
    ],
    "suggestions": [
        "2-4",
        "acutely",
        "administration & dosage",
        "adult",
        "adults",
        "aged",
        "and/or",
        "anti-n",
        "anti-rbd",
        "anti-s1",
        "antibodies",
        "anti\u2013sars-cov-2",
        "area",
        "assay",
        "binding",
        "blood",
        "combined",
        "compared",
        "complexity",
        "concentrations",
        "controls",
        "convalescent",
        "covid-19",
        "covid-19 vaccines",
        "covid-19-vaccinated",
        "curve",
        "develop",
        "developed",
        "development",
        "diagnosis",
        "disease",
        "displayed",
        "distinguish",
        "domain",
        "effect",
        "emory",
        "female",
        "geriatric",
        "healthy",
        "higher",
        "highly",
        "humans",
        "identifies",
        "iga",
        "igg",
        "igm",
        "immunoassay",
        "immunology",
        "infected",
        "infections",
        "kinetics",
        "levels",
        "lower",
        "magnitude",
        "male",
        "measured",
        "measurement",
        "measures",
        "metabolism",
        "method",
        "middle aged",
        "mild",
        "mild/moderate",
        "moderna",
        "mrna",
        "multiplex",
        "natural",
        "neutralization",
        "none",
        "nucleocapsid",
        "observed",
        "one-stop",
        "onset",
        "patients",
        "patients-a",
        "peak",
        "pediatric",
        "pfizer-biontech",
        "possible",
        "postpandemic",
        "prepandemic",
        "prevention & control",
        "previous",
        "protein",
        "prozone",
        "rbd",
        "reached",
        "response",
        "responses",
        "revealed",
        "rise",
        "rt-pcr\u2013confirmed",
        "s1-n-terminal",
        "s1-rbd",
        "s1-receptor",
        "sars-cov-2",
        "sars-cov-2-specific",
        "sars-cov-2\u2013infected",
        "sensitive",
        "sera",
        "serum",
        "serum/plasma",
        "severe",
        "severe/critical",
        "severity",
        "severity of illness index",
        "similar",
        "slower",
        "source",
        "specific",
        "spike",
        "strong",
        "studies",
        "study",
        "subjects",
        "symptom",
        "underestimated",
        "university",
        "using",
        "vaccination",
        "vaccine",
        "vaccines",
        "values",
        "viral",
        "virus-specific",
        "yielded",
        "\u22650.90"
    ]
}